🔗 Share this article

A shadow market for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Experimental Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of next-day British shipping. Sellers promote the drug there before directing buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Professionals Voice Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals administering products of unknown origin.

Some professionals stated the popularity for the experimental drug could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach medicines, advertising, and customer regulations, risking penalties, prosecution or prison.

Service Reaction and Content Elimination

Based on TikTok, the platform has taken down violative material and prohibited related keywords and search suggestions. The company said it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Online Trading Activities

Investigations also discovered groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, populated with photos of slimming results, positive reviews and detailed guides for preparing or administering at home.

Within minutes of entering one group, a vendor shared WhatsApp details, where most purchases take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Product Details and Pricing

Inside these groups, messages display black plastic packages with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with sterile water, or ready-to-use pens usually priced at £160 for 20 milligrams. When asked how much time a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it actively monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they cannot confirm. Although the research behind this drug is sound, these digital versions may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her team has previously seen patients injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental substance not yet authorized … may subject patients to potentially significant health risks”.